OM1

OM1 is a technology and data company based in Boston, Massachusetts. Employing 189 individuals, the company generates an annual revenue of $19 million. OM1 specializes in Personalized Medicine, Evidence Generation, and Real-World Evidence (RWE) Research. Their services are powered by next-generation AI platforms, regulatory-grade deep longitudinal data, and a reputation for global thought leadership. OM1's focus is on taking RWE from the research stage ("Bench") to practical application ("Practice"), aiming to deliver personalized improvements in patient outcomes and advance research. OM1 distinguishes itself through its commitment to innovation, integrating cutting-edge AI and data technologies to transform healthcare. They strive to set new industry benchmarks by enhancing patient outcomes and reimagining how industry stakeholders, providers, payers, and patients utilize real-world evidence. To learn more about OM1 and their services, visit their website at om1.com.